| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |